Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 40,750,133 $ 13,953,513
Accounts receivable 110,141 0
Prepaid research and development 107,000 774,356
Prepaid expenses and other current assets 1,502,725 54,837
Total assets 42,469,999 14,782,706
Current liabilities:    
Accounts payable 1,089,778 1,720,680
Accrued expenses and other current liabilities 2,715,761 632,934
Deferred revenue 0 2,325,741
Notes payable 248,911 42,534
Total 4,054,450 4,721,889
Notes payable, net of current portion 0 276,461
Total liabilities 4,054,450 4,998,350
Commitments and contingencies (see Note 10)
Stockholders' equity:    
Preferred stock, $0.001 par value; 10,000,000 and 0 shares authorized at December 31, 2021 and 2020; 0 shares issued and outstanding at December 31, 2021 and 2020 0 0
Common stock, $0.001 par value; 100,000,000 and 30,000,000 shares authorized; XX,XXX,XXX and 10,050,849 shares issued and outstanding at December 31, 2021 and 2020 25,155 10,051
Additional paid-in capital 68,208,081 24,805,929
Accumulated deficit (29,817,687) (15,031,624)
Total 38,415,549 9,784,356
Total liabilities and stockholders' equity $ 42,469,999 $ 14,782,706